Improvement in the range of joint motion in seven patients with mucopolysaccharidosis type II during experimental gene expression-targeted isoflavone therapy (GET IT)

Jolanta Marucha , Anna Tylki-Szymańska , Joanna Jakóbkiewicz-Banecka , Ewa Piotrowska , Anna Kloska , Barbara Czartoryska , Grzegorz Węgrzyn

Abstract

n/a
Author Jolanta Marucha
Jolanta Marucha,,
-
, Anna Tylki-Szymańska
Anna Tylki-Szymańska,,
-
, Joanna Jakóbkiewicz-Banecka (FB / DMBG)
Joanna Jakóbkiewicz-Banecka,,
- Katedra Biologii i Genetyki Medycznej
, Ewa Piotrowska (FB / DMoB)
Ewa Piotrowska,,
- Department of Molecular Biology
, Anna Kloska (FB / DMBG)
Anna Kloska,,
- Katedra Biologii i Genetyki Medycznej
, Barbara Czartoryska
Barbara Czartoryska,,
-
, Grzegorz Węgrzyn (FB / DMoB)
Grzegorz Węgrzyn,,
- Department of Molecular Biology
Journal seriesAmerican Journal of Medical Genetics Part A, ISSN 1552-4825, (A 20 pkt)
Issue year2011
Vol155
No9
Pages2257-2262
Keywords in Englishgene expression-targeted isoflavone therapy, genistein, Hunter disease, mucopolysaccharidoses, joint motion, substrate reduction therapy
DOIDOI:10.1002/ajmg.a.34146
URL http://onlinelibrary.wiley.com/doi/10.1002/ajmg.a.34146/pdf
Languageen angielski
Score (nominal)25
Publication indicators WoS Impact Factor: 2011 = 2.391 (2) - 2011=2.549 (5)
Citation count*
Cite
Share Share

Get link to the record


* presented citation count is obtained through Internet information analysis and it is close to the number calculated by the Publish or Perish system.
Back